{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:38:47Z","timestamp":1759451927720,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.vaccine.2018.02.061","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T10:06:10Z","timestamp":1519898770000},"page":"1871-1879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets"],"prefix":"10.1016","volume":"36","author":[{"given":"Rita","family":"Czak\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leatrice","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanta","family":"Subbarao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.02.061_b0005","unstructured":"Centers for Disease Control and Prevention. Hospitalizations and deaths from influenza. Clin Signs Symptoms Influenza Health Prof Seas Influenza Flu; 2016."},{"key":"10.1016\/j.vaccine.2018.02.061_b0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.virusres.2013.05.012","article-title":"The emergence and diversification of panzootic H5N1 influenza viruses","volume":"178","author":"Guan","year":"2013","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.02.061_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)30129-0","article-title":"Influenza","author":"Paules","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2018.02.061_b0020","first-page":"181","article-title":"Live attenuated influenza vaccine","volume":"386","author":"Hong","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2018.02.061_b0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.02.061_b0030","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199805143382002","article-title":"The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children","volume":"338","author":"Belshe","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.02.061_b0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jmv.1890170405","article-title":"Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine","volume":"17","author":"Johnson","year":"1985","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2018.02.061_b0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/jcm.24.1.157-160.1986","article-title":"Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus","volume":"24","author":"Clements","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.061_b0045","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0264-410X(99)00334-5","article-title":"Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses","volume":"18","author":"Treanor","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.061_b0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/infdis\/jir436","article-title":"Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children","volume":"204","author":"Hoft","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.061_b0055","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.1128\/JVI.01460-06","article-title":"Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines","volume":"80","author":"He","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.061_b0060","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/01.inf.0000237829.66310.85","article-title":"Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections","volume":"25","author":"Ashkenazi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.02.061_b0065","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/CVI.00397-07","article-title":"Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children","volume":"15","author":"Forrest","year":"2008","journal-title":"Clin Vaccine Immunol CVI"},{"key":"10.1016\/j.vaccine.2018.02.061_b0070","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/infdis\/jiu190","article-title":"Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines","volume":"210","author":"Sasaki","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.061_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines","volume":"59","author":"Cox","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2018.02.061_b0080","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0264-410X(01)00471-6","article-title":"Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy: a meta-analysis","volume":"20","author":"Beyer","year":"2002","journal-title":"Vaccine"},{"issue":"173","key":"10.1016\/j.vaccine.2018.02.061_b0085","first-page":"1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"1950","author":"Renegar","year":"2004","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.vaccine.2018.02.061_b0090","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1164\/rccm.201309-1616OC","article-title":"Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load","volume":"189","author":"Oshansky","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"178","key":"10.1016\/j.vaccine.2018.02.061_b0095","first-page":"1030","article-title":"Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus","volume":"1950","author":"Powell","year":"2007","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.vaccine.2018.02.061_b0100","unstructured":"World Health Organization. Pandemic influenza preparedness Framework. WHO; 2011."},{"key":"10.1016\/j.vaccine.2018.02.061_b0105","unstructured":"World Health Organization. Global pandemic influenza action plan to increase vaccine supply; 2006."},{"key":"10.1016\/j.vaccine.2018.02.061_b0110","doi-asserted-by":"crossref","unstructured":"Chen Grace L, Subbarao Kanta. Live attenuated vaccines for pandemic influenza. Curr Top Microbiol Immunol 2009;333.","DOI":"10.1007\/978-3-540-92165-3_5"},{"key":"10.1016\/j.vaccine.2018.02.061_b0115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1586\/14760584.2015.979159","article-title":"Pandemic preparedness with live attenuated influenza vaccines based on A\/Leningrad\/134\/17\/57 master donor virus","volume":"14","author":"Rudenko","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.02.061_b0120","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.vaccine.2009.05.099","article-title":"Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults","volume":"27","author":"Karron","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.061_b0125","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/infdis\/jiu123","article-title":"A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response","volume":"209","author":"Talaat","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.061_b0130","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1473-3099(17)30240-2","article-title":"Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A\/17\/turkey\/Turkey\/05\/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial","volume":"17","author":"Pitisuttithum","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.061_b0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.coviro.2015.06.002","article-title":"Animal models for influenza virus transmission studies: a historical perspective","volume":"13","author":"Bouvier","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2018.02.061_b0140","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2018.02.061_b0145","doi-asserted-by":"crossref","first-page":"6907","DOI":"10.1128\/JVI.00280-15","article-title":"A single dose of an avian H3N8 influenza virus vaccine is highly immunogenic and efficacious against a recently emerged seal influenza virus in mice and ferrets","volume":"89","author":"Baz","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.061_b0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.02.061_b0155","doi-asserted-by":"crossref","first-page":"11725","DOI":"10.1128\/JVI.01477-12","article-title":"Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium","volume":"86","author":"Ilyushina","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.061_b0160","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1016\/j.vaccine.2015.07.023","article-title":"Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells","volume":"33","author":"Fischer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.061_b0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0166-0934(89)90004-9","article-title":"Assessment of signs of influenza illness in the ferret model","volume":"24","author":"Reuman","year":"1989","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2018.02.061_b0170","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0042-6822(02)00035-1","article-title":"Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (flumist) derived from cold-adapted a\/ann arbor\/6\/60","volume":"306","author":"Jin","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.02.061_b0175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.virol.2011.01.004","article-title":"Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A\/Leningrad\/134\/17\/57 (H2N2)","volume":"412","author":"Isakova-Sivak","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.02.061_b0180","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1371\/journal.pmed.0030360","article-title":"Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets","volume":"3","author":"Suguitan","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2018.02.061_b0185","unstructured":"Nicholson KG, Tyrrell DAJ, Oxford JS, Wood J, Schild GC, Potter CW, et al. Infectivity and reactogenicity of reassortant cold-adapted influenza; 1987."},{"key":"10.1016\/j.vaccine.2018.02.061_b0190","doi-asserted-by":"crossref","first-page":"e1000424","DOI":"10.1371\/journal.ppat.1000424","article-title":"Avian influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways","volume":"5","author":"Scull","year":"2009","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.vaccine.2018.02.061_b0195","unstructured":"Committee for Proprietary Medicinal Products. Note for guidance on harmonization of requirements for influenza vaccines. The European Agency for the Evaluation of Medicinal Products; 1997."},{"key":"10.1016\/j.vaccine.2018.02.061_b0200","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/infdis\/jir661","article-title":"Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection","volume":"204","author":"Ohmit","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.061_b0205","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/507709","article-title":"Cross-protectiveness and immunogenicity of influenza A\/Duck\/Singapore\/3\/97(H5) vaccines against infection with A\/Vietnam\/1203\/04(H5N1) virus in ferrets","volume":"194","author":"Lipatov","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.061_b0210","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/infdis\/169.1.68","article-title":"A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease","volume":"169","author":"Edwards","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.061_b0215","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1586\/erv.11.73","article-title":"Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference","volume":"10","author":"Bandell","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.02.061_b0220","doi-asserted-by":"crossref","first-page":"44727","DOI":"10.1038\/srep44727","article-title":"The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants","volume":"7","author":"Wong","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2018.02.061_b0225","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/infdis\/jir596","article-title":"Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets","volume":"204","author":"Gustin","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.061_b0230","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1016\/j.vaccine.2015.08.019","article-title":"Clinical testing of pre-pandemic live attenuated A\/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study","volume":"33","author":"Rudenko","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:04Z","timestamp":1759400704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18302482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":46,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0264410X18302482"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}